{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:04Z","timestamp":1786119304056,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/cji.0b013e3181987c22","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T03:20:06Z","timestamp":1245295206000},"page":"539-551","source":"Crossref","is-referenced-by-count":12,"title":["Efficient Activation of LRH-1\u2013specific CD8+ T-cell Responses From Transplanted Leukemia Patients by Stimulation With P2X5 mRNA-electroporated Dendritic Cells"],"prefix":"10.1097","volume":"32","author":[{"given":"Ingrid M.","family":"Overes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Fredrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel G.D.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Frederik Falkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"van der Voort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo M.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Dolstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210208","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0268-960X(03)00007-9","article-title":"The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Riddell","year":"2003","journal-title":"Blood Rev"},{"key":"R2-1-20210208","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc1365","article-title":"Molecules and mechanisms of the graft-versus-leukaemia effect","volume":"4","author":"Bleakley","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R3-1-20210208","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","article-title":"Effector and memory CTL differentiation","volume":"25","author":"Williams","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"R4-1-20210208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"Harty","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R5-1-20210208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00384.x","article-title":"Programming, demarcating, and manipulating CD8+ T-cell memory","volume":"211","author":"Badovinac","year":"2006","journal-title":"Immunol Rev"},{"key":"R6-1-20210208","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1172\/JCI24832","article-title":"A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia","volume":"115","author":"de Rijke","year":"2005","journal-title":"J Clin Invest"},{"key":"R7-1-20210208","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/sj.leu.2404838","article-title":"Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning","volume":"21","author":"Hoogendoorn","year":"2007","journal-title":"Leukemia"},{"key":"R8-1-20210208","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.95.17.10152","article-title":"T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation","volume":"95","author":"Smit","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-1-20210208","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-1-20210208","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bmt.1700778","article-title":"Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation","volume":"19","author":"Dermime","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R11-1-20210208","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"R12-1-20210208","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0301-472X(03)00190-5","article-title":"Minor histocompatibility antigens in human stem cell transplantation","volume":"31","author":"Falkenburg","year":"2003","journal-title":"Exp Hematol"},{"key":"R13-1-20210208","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1349-7006.2007.00521.x","article-title":"Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions","volume":"98","author":"Akatsuka","year":"2007","journal-title":"Cancer Sci"},{"key":"R14-1-20210208","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1311","article-title":"T cells targeted against a single minor histocompatibility antigen can cure solid tumors","volume":"11","author":"Meunier","year":"2005","journal-title":"Nat Med"},{"key":"R15-1-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2005.02.006","article-title":"T cell immunity and graft-versus-host disease (GVHD)","volume":"5","author":"Ichiki","year":"2006","journal-title":"Autoimmun Rev"},{"key":"R16-1-20210208","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.1997.tb00978.x","article-title":"Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy","volume":"157","author":"Goulmy","year":"1997","journal-title":"Immunol Rev"},{"key":"R17-1-20210208","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0966-3274(96)80009-8","article-title":"Functional expression of minor histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells","volume":"4","author":"van Lochem","year":"1996","journal-title":"Transpl Immunol"},{"key":"R18-1-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2007.00575.x","article-title":"Taming cancer by inducing immunity via dendritic cells","volume":"220","author":"Palucka","year":"2007","journal-title":"Immunol Rev"},{"key":"R19-1-20210208","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0952-7915(03)00015-3","article-title":"The use of dendritic cells in cancer immunotherapy","volume":"15","author":"Schuler","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"R20-1-20210208","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002371-200207000-00001","article-title":"Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity","volume":"25","author":"Zhou","year":"2002","journal-title":"J Immunother (1997)"},{"key":"R21-1-20210208","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4049\/jimmunol.169.4.1669","article-title":"Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells","volume":"169","author":"Ponsaerts","year":"2002","journal-title":"J Immunol"},{"key":"R22-1-20210208","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V98.1.49","article-title":"Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells","volume":"98","author":"van Tendeloo","year":"2001","journal-title":"Blood"},{"key":"R23-1-20210208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-1759(01)00506-3","article-title":"mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)","volume":"259","author":"Saeboe-Larssen","year":"2002","journal-title":"J Immunol Methods"},{"key":"R24-1-20210208","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1172\/JCI11405","article-title":"RNA-transfected dendritic cells in cancer immunotherapy","volume":"106","author":"Mitchell","year":"2000","journal-title":"J Clin Invest"},{"key":"R25-1-20210208","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2141.2008.07125.x","article-title":"Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis","volume":"141","author":"Overes","year":"2008","journal-title":"Br J Haematol"},{"key":"R26-1-20210208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00262-008-0569-3","article-title":"Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis","volume":"58","author":"Overes","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"R28-1-20210208","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.174.5.3087","article-title":"Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation","volume":"174","author":"Schaft","year":"2005","journal-title":"J Immunol"},{"key":"R29-1-20210208","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.gt.3302471","article-title":"Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines","volume":"12","author":"Michiels","year":"2005","journal-title":"Gene Ther"},{"key":"R30-1-20210208","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R31-1-20210208","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm1039","article-title":"Dendritic cell immunotherapy: mapping the way","volume":"10","author":"Figdor","year":"2004","journal-title":"Nat Med"},{"key":"R32-1-20210208","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.critrevonc.2007.12.007","article-title":"Dendritic cell vaccines in melanoma: from promise to proof?","volume":"66","author":"Lesterhuis","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"R33-1-20210208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.critrevonc.2007.10.002","article-title":"The use of dendritic cells in cancer immunotherapy","volume":"65","author":"Nencioni","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"R34-1-20210208","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/CJI.0b013e31818403bc","article-title":"Dendritic cells: a critical player in cancer therapy?","volume":"31","author":"Palucka","year":"2008","journal-title":"J Immunother"},{"key":"R35-1-20210208","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2003-01-0183","article-title":"IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro","volume":"102","author":"Alves","year":"2003","journal-title":"Blood"},{"key":"R36-1-20210208","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.coi.2007.04.015","article-title":"Cytokines and T-cell homeostasis","volume":"19","author":"Boyman","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"R37-1-20210208","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat Med"},{"key":"R38-1-20210208","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nri1254","article-title":"Human CD8(+) T-cell differentiation in response to viruses","volume":"3","author":"van Lier","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R39-1-20210208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0105-2896.2006.00379.x","article-title":"Human virus-specific CD8+ T cells: diversity specialists","volume":"211","author":"van Leeuwen","year":"2006","journal-title":"Immunol Rev"},{"key":"R40-1-20210208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/80877","article-title":"CD27 is required for generation and long-term maintenance of T cell immunity","volume":"1","author":"Hendriks","year":"2000","journal-title":"Nat Immunol"},{"key":"R41-1-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","article-title":"TNF\/TNFR family members in costimulation of T cell responses","volume":"23","author":"Watts","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R42-1-20210208","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.cji.0000165357.11548.6d","article-title":"A novel flow cytometric assay for evaluating cell-mediated cytotoxicity","volume":"28","author":"Burkett","year":"2005","journal-title":"J Immunother (1997)"},{"key":"R43-1-20210208","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R44-1-20210208","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood.V93.7.2336","article-title":"Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens","volume":"93","author":"Mutis","year":"1999","journal-title":"Blood"},{"key":"R45-1-20210208","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/bbmt.2002.v8.pm12234166","article-title":"Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA","volume":"8","author":"Mutis","year":"2002","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e3181987c22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:58Z","timestamp":1786039138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200907000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181987c22","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}